Document is current
Any future updates will be listed below
-
Authors
Xu, Christine
Zhang, Mei
Liu, Ying
Baret-Cormel, Lydie
De Benedetti, Fabrizio
Abdallah, Hisham
Kanamaluru, Vanaja
Meng, Zhaoling
-
Funding
Funding for this research was provided by:
Sanofi and Regeneron Pharmaceuticals Inc.
- License Information
-
More Information
Article History
Received: 11 July 2025
Accepted: 4 February 2026
First Online: 24 March 2026
Declarations
:
: CX, MZ, YL, LB-C, VK, and ZM are employees of Sanofi and may hold stocks and other ownership interests in the company. FDB received consultancy and unrestricted grants from AbbVie, Pfizer, Sanofi, Roche, Novartis, Sobi, Apollo, and Elixiron. HA is an employee of Regeneron Pharmaceuticals Inc. and may hold stocks and other ownership interests in the company.
